| 1 | [SID46393660] | Active | | | Experimentally measured binding affinity data derived from PDB [AID1811, Type: Literature] | Chain A, Schiff-Base Complex Of Yeast 5-Aminolaevulinic Acid Dehydratase With Laevulinic Acid [gi:7245674] |   View X | Row No. | 1 | | Structure |
| | Substance | | | SID | 46393660 | | CID | 7991 | | Outcome | Active | | BioAssay | Experimentally measured binding affinity data derived from PDB | | AID | 1811 | | BioAssay type | Literature | | Target | Chain A, Schiff-Base Complex Of Yeast 5-Aminolaevulinic Acid Dehydratase With Laevulinic Acid [gi:7245674] | | PubMed | 10386874 | | Data Table |  |
|
| 2 | [SID103176196] | Unspecified | | | Partition coefficient (logP) [AID23251, Type: Literature] | |   View X | Row No. | 2 | | Structure |
| | Substance | | | SID | 103176196 | | CID | 7991 | | Outcome | Unspecified | | BioAssay | Partition coefficient (logP) | | AID | 23251 | | BioAssay type | Literature | | Target | | | PubMed | 3599019 | | Data Table |  |
|
| 3 | [SID103176196] | Unspecified | | | Partition coefficient (logP) (benzene) [AID23252, Type: Literature] | |   View X | Row No. | 3 | | Structure |
| | Substance | | | SID | 103176196 | | CID | 7991 | | Outcome | Unspecified | | BioAssay | Partition coefficient (logP) (benzene) | | AID | 23252 | | BioAssay type | Literature | | Target | | | PubMed | 3599019 | | Data Table |  |
|
| 4 | [SID103176196] | Unspecified | | | Partition coefficient (logP) (carbon tetrachloride) [AID23253, Type: Literature] | |   View X | Row No. | 4 | | Structure |
| | Substance | | | SID | 103176196 | | CID | 7991 | | Outcome | Unspecified | | BioAssay | Partition coefficient (logP) (carbon tetrachloride) | | AID | 23253 | | BioAssay type | Literature | | Target | | | PubMed | 3599019 | | Data Table |  |
|
| 5 | [SID103176196] | Unspecified | | | Partition coefficient (logP) (chloroform) [AID23254, Type: Literature] | |   View X | Row No. | 5 | | Structure |
| | Substance | | | SID | 103176196 | | CID | 7991 | | Outcome | Unspecified | | BioAssay | Partition coefficient (logP) (chloroform) | | AID | 23254 | | BioAssay type | Literature | | Target | | | PubMed | 3599019 | | Data Table |  |
|
| 6 | [SID103176196] | Unspecified | | | Partition coefficient (logP) (ether) [AID23255, Type: Literature] | |   View X | Row No. | 6 | | Structure |
| | Substance | | | SID | 103176196 | | CID | 7991 | | Outcome | Unspecified | | BioAssay | Partition coefficient (logP) (ether) | | AID | 23255 | | BioAssay type | Literature | | Target | | | PubMed | 3599019 | | Data Table |  |
|
| 7 | [SID103176196] | Unspecified | | | Partition coefficient (logP) (hexane) [AID23256, Type: Literature] | |   View X | Row No. | 7 | | Structure |
| | Substance | | | SID | 103176196 | | CID | 7991 | | Outcome | Unspecified | | BioAssay | Partition coefficient (logP) (hexane) | | AID | 23256 | | BioAssay type | Literature | | Target | | | PubMed | 3599019 | | Data Table |  |
|
| 8 | [SID103176196] | Unspecified | | | Inhibition of HDAC in human Hela cells nuclear extracts assessed as residual activity at 500 uM by fluorimetric assay [AID447578, Type: Literature] | |   View X | Row No. | 8 | | Structure |
| | Substance | | | SID | 103176196 | | CID | 7991 | | Outcome | Unspecified | | BioAssay | Inhibition of HDAC in human Hela cells nuclear extracts assessed as residual activity at 500 uM by fluorimetric assay | | AID | 447578 | | BioAssay type | Literature | | Target | | | PubMed | 19520580 | | Data Table |  |
|
| 9 | [SID103176196] | Unspecified | | | Human drug-induced liver injury (DILI) modelling dataset from Ekins et al [AID588210, Type: Literature] | |   View X | Row No. | 9 | | Structure |
| | Substance | | | SID | 103176196 | | CID | 7991 | | Outcome | Unspecified | | BioAssay | Human drug-induced liver injury (DILI) modelling dataset from Ekins et al | | AID | 588210 | | BioAssay type | Literature | | Target | | | PubMed | 20843939 | | Data Table |  |
|
| 10 | [SID47193677] | Unspecified | Potency | | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate [AID624178, Type: confirmatory] | acid sphingomyelinase [Homo sapiens] [gi:179095] |  View X | Row No. | 10 | | Structure |
| | Substance | | | SID | 47193677 | | CID | 7991 | | Outcome | Unspecified | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate | | AID | 624178 | | BioAssay type | confirmatory | | Target | acid sphingomyelinase [Homo sapiens] [gi:179095] | | PubMed | | | Data Table |  |
|
| 11 | [SID47193677] | Unspecified | Potency | | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate [AID624178, Type: confirmatory] | acid sphingomyelinase [Homo sapiens] [gi:179095] |  View X | Row No. | 11 | | Structure |
| | Substance | | | SID | 47193677 | | CID | 7991 | | Outcome | Unspecified | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate | | AID | 624178 | | BioAssay type | confirmatory | | Target | acid sphingomyelinase [Homo sapiens] [gi:179095] | | PubMed | | | Data Table |  |
|
| 12 | [SID47193677] | Inactive | Potency | 0.8913 | qHTS for Agonist of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS [AID624287, Type: confirmatory] | Guanine nucleotide-binding protein G(s) subunit alpha isoforms short [gi:52000961] |  View X | Row No. | 12 | | Structure |
| | Substance | | | SID | 47193677 | | CID | 7991 | | Outcome | Inactive | | Potency | 0.8913 [uM] | | BioAssay | qHTS for Agonist of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS | | AID | 624287 | | BioAssay type | confirmatory | | Target | Guanine nucleotide-binding protein G(s) subunit alpha isoforms short [gi:52000961] | | PubMed | | | Data Table |  |
|
| 13 | [SID47193677] | Inactive | Potency | | qHTS for Antagonists of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS [AID624288, Type: confirmatory] | Guanine nucleotide-binding protein G(s) subunit alpha isoforms short [gi:52000961] |  View X | Row No. | 13 | | Structure |
| | Substance | | | SID | 47193677 | | CID | 7991 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS for Antagonists of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS | | AID | 624288 | | BioAssay type | confirmatory | | Target | Guanine nucleotide-binding protein G(s) subunit alpha isoforms short [gi:52000961] | | PubMed | | | Data Table |  |
|
| 14 | [SID47193677] | Inactive | | | Luminescence Cell-Free Homogenous Primary HTS to Identify Inhibitors of GSK-3 alpha [AID2650, Type: screening] | GSK3A gene product [Homo sapiens] [gi:49574532] |  View X | Row No. | 14 | | Structure |
| | Substance | | | SID | 47193677 | | CID | 7991 | | Outcome | Inactive | | BioAssay | Luminescence Cell-Free Homogenous Primary HTS to Identify Inhibitors of GSK-3 alpha | | AID | 2650 | | BioAssay type | screening | | Target | GSK3A gene product [Homo sapiens] [gi:49574532] | | PubMed | | | Data Table |  |
|
| 15 | [SID47193677] | Inactive | | | Luminescence Cell-Free Homogenous Primary HTS to Identify Inhibitors of GSK-3 alpha [AID2650, Type: screening] | GSK3A gene product [Homo sapiens] [gi:49574532] |  View X | Row No. | 15 | | Structure |
| | Substance | | | SID | 47193677 | | CID | 7991 | | Outcome | Inactive | | BioAssay | Luminescence Cell-Free Homogenous Primary HTS to Identify Inhibitors of GSK-3 alpha | | AID | 2650 | | BioAssay type | screening | | Target | GSK3A gene product [Homo sapiens] [gi:49574532] | | PubMed | | | Data Table |  |
|
| 16 | [SID47193677] | Inactive | | | Cell-Free Homogeneous Primary HTS to Identify Inhibitors of GSK3beta Activity [AID2097, Type: screening] | GSK3B gene product [Homo sapiens] [gi:21361340] |  View X | Row No. | 16 | | Structure |
| | Substance | | | SID | 47193677 | | CID | 7991 | | Outcome | Inactive | | BioAssay | Cell-Free Homogeneous Primary HTS to Identify Inhibitors of GSK3beta Activity | | AID | 2097 | | BioAssay type | screening | | Target | GSK3B gene product [Homo sapiens] [gi:21361340] | | PubMed | | | Data Table |  |
|
| 17 | [SID47193677] | Inactive | | | Cell-Free Homogeneous Primary HTS to Identify Inhibitors of GSK3beta Activity [AID2097, Type: screening] | GSK3B gene product [Homo sapiens] [gi:21361340] |  View X | Row No. | 17 | | Structure |
| | Substance | | | SID | 47193677 | | CID | 7991 | | Outcome | Inactive | | BioAssay | Cell-Free Homogeneous Primary HTS to Identify Inhibitors of GSK3beta Activity | | AID | 2097 | | BioAssay type | screening | | Target | GSK3B gene product [Homo sapiens] [gi:21361340] | | PubMed | | | Data Table |  |
|
| 18 | [SID47193677] | Inactive | | | Cell-Free Homogeneous Primary HTS to Identify Inhibitors of GSK3beta Activity [AID2097, Type: screening] | GSK3B gene product [Homo sapiens] [gi:21361340] |  View X | Row No. | 18 | | Structure |
| | Substance | | | SID | 47193677 | | CID | 7991 | | Outcome | Inactive | | BioAssay | Cell-Free Homogeneous Primary HTS to Identify Inhibitors of GSK3beta Activity | | AID | 2097 | | BioAssay type | screening | | Target | GSK3B gene product [Homo sapiens] [gi:21361340] | | PubMed | | | Data Table |  |
|
| 19 | [SID47193677] | Inactive | | | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the orexin 1 receptor (OX1R; HCRTR1) [AID434989, Type: screening] | orexin receptor type 1 [Homo sapiens] [gi:222080095] |  View X | Row No. | 19 | | Structure |
| | Substance | | | SID | 47193677 | | CID | 7991 | | Outcome | Inactive | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the orexin 1 receptor (OX1R; HCRTR1) | | AID | 434989 | | BioAssay type | screening | | Target | orexin receptor type 1 [Homo sapiens] [gi:222080095] | | PubMed | | | Data Table |  |
|
| 20 | [SID47193677] | Inactive | | | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the orexin 1 receptor (OX1R; HCRTR1) [AID434989, Type: screening] | orexin receptor type 1 [Homo sapiens] [gi:222080095] |  View X | Row No. | 20 | | Structure |
| | Substance | | | SID | 47193677 | | CID | 7991 | | Outcome | Inactive | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the orexin 1 receptor (OX1R; HCRTR1) | | AID | 434989 | | BioAssay type | screening | | Target | orexin receptor type 1 [Homo sapiens] [gi:222080095] | | PubMed | | | Data Table |  |
|
| 21 | [SID47193677] | Inactive | | | FRET-based cell-based primary high throughput screening assay to identify antagonists of the orexin 1 receptor (OX1R; HCRTR1) [AID485270, Type: screening] | orexin receptor type 1 [Homo sapiens] [gi:222080095] |  View X | Row No. | 21 | | Structure |
| | Substance | | | SID | 47193677 | | CID | 7991 | | Outcome | Inactive | | BioAssay | FRET-based cell-based primary high throughput screening assay to identify antagonists of the orexin 1 receptor (OX1R; HCRTR1) | | AID | 485270 | | BioAssay type | screening | | Target | orexin receptor type 1 [Homo sapiens] [gi:222080095] | | PubMed | | | Data Table |  |
|
| 22 | [SID47193677] | Inactive | | | FRET-based cell-based primary high throughput screening assay to identify antagonists of the orexin 1 receptor (OX1R; HCRTR1) [AID485270, Type: screening] | orexin receptor type 1 [Homo sapiens] [gi:222080095] |  View X | Row No. | 22 | | Structure |
| | Substance | | | SID | 47193677 | | CID | 7991 | | Outcome | Inactive | | BioAssay | FRET-based cell-based primary high throughput screening assay to identify antagonists of the orexin 1 receptor (OX1R; HCRTR1) | | AID | 485270 | | BioAssay type | screening | | Target | orexin receptor type 1 [Homo sapiens] [gi:222080095] | | PubMed | | | Data Table |  |
|
| 23 | [SID47193677] | Inactive | | | Fluorescence polarization-based cell-based primary high throughput screening assay to identify inhibitors of insulin-degrading enzyme (IDE) [AID434962, Type: screening] | IDE gene product [Homo sapiens] [gi:155969707] |  View X | Row No. | 23 | | Structure |
| | Substance | | | SID | 47193677 | | CID | 7991 | | Outcome | Inactive | | BioAssay | Fluorescence polarization-based cell-based primary high throughput screening assay to identify inhibitors of insulin-degrading enzyme (IDE) | | AID | 434962 | | BioAssay type | screening | | Target | IDE gene product [Homo sapiens] [gi:155969707] | | PubMed | | | Data Table |  |
|
| 24 | [SID47193677] | Inactive | Potency | | qHTS for Inhibitors of mutant isocitrate dehydrogenase 1 (IDH1): qHTS [AID602179, Type: confirmatory] | isocitrate dehydrogenase 1 [Homo sapiens] [gi:89573979] |  View X | Row No. | 24 | | Structure |
| | Substance | | | SID | 47193677 | | CID | 7991 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of mutant isocitrate dehydrogenase 1 (IDH1): qHTS | | AID | 602179 | | BioAssay type | confirmatory | | Target | isocitrate dehydrogenase 1 [Homo sapiens] [gi:89573979] | | PubMed | | | Data Table |  |
|
| 25 | [SID47193677] | Inactive | Potency | | qHTS for Inhibitors of mutant isocitrate dehydrogenase 1 (IDH1): qHTS [AID602179, Type: confirmatory] | isocitrate dehydrogenase 1 [Homo sapiens] [gi:89573979] |  View X | Row No. | 25 | | Structure |
| | Substance | | | SID | 47193677 | | CID | 7991 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of mutant isocitrate dehydrogenase 1 (IDH1): qHTS | | AID | 602179 | | BioAssay type | confirmatory | | Target | isocitrate dehydrogenase 1 [Homo sapiens] [gi:89573979] | | PubMed | | | Data Table |  |
|
| 26 | [SID47193677] | Inactive | Potency | | qHTS for Inhibitors of mutant isocitrate dehydrogenase 1 (IDH1): qHTS [AID602179, Type: confirmatory] | isocitrate dehydrogenase 1 [Homo sapiens] [gi:89573979] |  View X | Row No. | 26 | | Structure |
| | Substance | | | SID | 47193677 | | CID | 7991 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of mutant isocitrate dehydrogenase 1 (IDH1): qHTS | | AID | 602179 | | BioAssay type | confirmatory | | Target | isocitrate dehydrogenase 1 [Homo sapiens] [gi:89573979] | | PubMed | | | Data Table |  |
|
| 27 | [SID47193677] | Inactive | Potency | | qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-NT fibrosarcoma cell line [AID686970, Type: confirmatory] | IDH1 [Homo sapiens] [gi:49168486] |  View X | Row No. | 27 | | Structure |
| | Substance | | | SID | 47193677 | | CID | 7991 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-NT fibrosarcoma cell line | | AID | 686970 | | BioAssay type | confirmatory | | Target | IDH1 [Homo sapiens] [gi:49168486] | | PubMed | | | Data Table |  |
|
| 28 | [SID47193677] | Inactive | Potency | | qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-NT fibrosarcoma cell line [AID686970, Type: confirmatory] | IDH1 [Homo sapiens] [gi:49168486] |  View X | Row No. | 28 | | Structure |
| | Substance | | | SID | 47193677 | | CID | 7991 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-NT fibrosarcoma cell line | | AID | 686970 | | BioAssay type | confirmatory | | Target | IDH1 [Homo sapiens] [gi:49168486] | | PubMed | | | Data Table |  |
|
| 29 | [SID47193677] | Inactive | Potency | | qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-NT fibrosarcoma cell line [AID686970, Type: confirmatory] | IDH1 [Homo sapiens] [gi:49168486] |  View X | Row No. | 29 | | Structure |
| | Substance | | | SID | 47193677 | | CID | 7991 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-NT fibrosarcoma cell line | | AID | 686970 | | BioAssay type | confirmatory | | Target | IDH1 [Homo sapiens] [gi:49168486] | | PubMed | | | Data Table |  |
|
| 30 | [SID47193677] | Inactive | | | HTS for Identification of VLA-4 Allosteric Modulators from MLPCN library [AID2557, Type: screening] | integrin alpha-4 precursor [Homo sapiens] [gi:67191027] |  View X | Row No. | 30 | | Structure |
| | Substance | | | SID | 47193677 | | CID | 7991 | | Outcome | Inactive | | BioAssay | HTS for Identification of VLA-4 Allosteric Modulators from MLPCN library | | AID | 2557 | | BioAssay type | screening | | Target | integrin alpha-4 precursor [Homo sapiens] [gi:67191027] | | PubMed | | | Data Table |  |
|
| 31 | [SID47193677] | Inactive | | | HTS for Identification of VLA-4 Allosteric Modulators from MLPCN library [AID2557, Type: screening] | integrin alpha-4 precursor [Homo sapiens] [gi:67191027] |  View X | Row No. | 31 | | Structure |
| | Substance | | | SID | 47193677 | | CID | 7991 | | Outcome | Inactive | | BioAssay | HTS for Identification of VLA-4 Allosteric Modulators from MLPCN library | | AID | 2557 | | BioAssay type | screening | | Target | integrin alpha-4 precursor [Homo sapiens] [gi:67191027] | | PubMed | | | Data Table |  |
|
| 32 | [SID47193677] | Inactive | | | Primary cell-based high-throughput screening assay for identification of compounds that protect hERG from block by proarrhythmic agents [AID1511, Type: screening] | putative potassium channel subunit [Homo sapiens] [gi:487738] |  View X | Row No. | 32 | | Structure |
| | Substance | | | SID | 47193677 | | CID | 7991 | | Outcome | Inactive | | BioAssay | Primary cell-based high-throughput screening assay for identification of compounds that protect hERG from block by proarrhythmic agents | | AID | 1511 | | BioAssay type | screening | | Target | putative potassium channel subunit [Homo sapiens] [gi:487738] | | PubMed | | | Data Table |  |
|
| 33 | [SID47193677] | Inactive | | | Primary cell-based high-throughput screening assay for identification of compounds that protect hERG from block by proarrhythmic agents [AID1511, Type: screening] | putative potassium channel subunit [Homo sapiens] [gi:487738] |  View X | Row No. | 33 | | Structure |
| | Substance | | | SID | 47193677 | | CID | 7991 | | Outcome | Inactive | | BioAssay | Primary cell-based high-throughput screening assay for identification of compounds that protect hERG from block by proarrhythmic agents | | AID | 1511 | | BioAssay type | screening | | Target | putative potassium channel subunit [Homo sapiens] [gi:487738] | | PubMed | | | Data Table |  |
|
| 34 | [SID47193677] | Inactive | | | Primary cell-based high-throughput screening assay for identification of compounds that protect hERG from block by proarrhythmic agents [AID1511, Type: screening] | putative potassium channel subunit [Homo sapiens] [gi:487738] |  View X | Row No. | 34 | | Structure |
| | Substance | | | SID | 47193677 | | CID | 7991 | | Outcome | Inactive | | BioAssay | Primary cell-based high-throughput screening assay for identification of compounds that protect hERG from block by proarrhythmic agents | | AID | 1511 | | BioAssay type | screening | | Target | putative potassium channel subunit [Homo sapiens] [gi:487738] | | PubMed | | | Data Table |  |
|
| 35 | [SID47193677] | Inactive | | | Primary cell-based high-throughput screening assay for identification of compounds that protect hERG from block by proarrhythmic agents [AID1511, Type: screening] | putative potassium channel subunit [Homo sapiens] [gi:487738] |  View X | Row No. | 35 | | Structure |
| | Substance | | | SID | 47193677 | | CID | 7991 | | Outcome | Inactive | | BioAssay | Primary cell-based high-throughput screening assay for identification of compounds that protect hERG from block by proarrhythmic agents | | AID | 1511 | | BioAssay type | screening | | Target | putative potassium channel subunit [Homo sapiens] [gi:487738] | | PubMed | | | Data Table |  |
|
| 36 | [SID47193677] | Inactive | | | Primary cell-based high-throughput screening assay for identification of compounds that protect hERG from block by proarrhythmic agents [AID1511, Type: screening] | putative potassium channel subunit [Homo sapiens] [gi:487738] |  View X | Row No. | 36 | | Structure |
| | Substance | | | SID | 47193677 | | CID | 7991 | | Outcome | Inactive | | BioAssay | Primary cell-based high-throughput screening assay for identification of compounds that protect hERG from block by proarrhythmic agents | | AID | 1511 | | BioAssay type | screening | | Target | putative potassium channel subunit [Homo sapiens] [gi:487738] | | PubMed | | | Data Table |  |
|
| 37 | [SID47193677] | Inactive | | | Primary cell-based high-throughput screening assay for identification of compounds that inhibit KCNQ1 potassium channels [AID2642, Type: screening] | KCNQ1 gene product [Homo sapiens] [gi:32479527] |  View X | Row No. | 37 | | Structure |
| | Substance | | | SID | 47193677 | | CID | 7991 | | Outcome | Inactive | | BioAssay | Primary cell-based high-throughput screening assay for identification of compounds that inhibit KCNQ1 potassium channels | | AID | 2642 | | BioAssay type | screening | | Target | KCNQ1 gene product [Homo sapiens] [gi:32479527] | | PubMed | | | Data Table |  |
|
| 38 | [SID47193677] | Inactive | | | Primary cell-based high-throughput screening assay for identification of compounds that potentiate/activate KCNQ1 potassium channels [AID2648, Type: screening] | KCNQ1 gene product [Homo sapiens] [gi:32479527] |  View X | Row No. | 38 | | Structure |
| | Substance | | | SID | 47193677 | | CID | 7991 | | Outcome | Inactive | | BioAssay | Primary cell-based high-throughput screening assay for identification of compounds that potentiate/activate KCNQ1 potassium channels | | AID | 2648 | | BioAssay type | screening | | Target | KCNQ1 gene product [Homo sapiens] [gi:32479527] | | PubMed | | | Data Table |  |
|
| 39 | [SID47193677] | Inactive | Potency | | qHTS for Inhibitors of TGF-b [AID588855, Type: confirmatory] | Smad3 [Homo sapiens] [gi:18418623] |  View X | Row No. | 39 | | Structure |
| | Substance | | | SID | 47193677 | | CID | 7991 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of TGF-b | | AID | 588855 | | BioAssay type | confirmatory | | Target | Smad3 [Homo sapiens] [gi:18418623] | | PubMed | | | Data Table |  |
|
| 40 | [SID47193677] | Inactive | Potency | | qHTS for Inhibitors of TGF-b [AID588855, Type: confirmatory] | Smad3 [Homo sapiens] [gi:18418623] |  View X | Row No. | 40 | | Structure |
| | Substance | | | SID | 47193677 | | CID | 7991 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of TGF-b | | AID | 588855 | | BioAssay type | confirmatory | | Target | Smad3 [Homo sapiens] [gi:18418623] | | PubMed | | | Data Table |  |
|
| 41 | [SID47193677] | Inactive | | | Luminescence-based cell-based primary high throughput screening assay to identify biased ligands of the melanocortin 4 receptor (MC4R): agonists of MC4R [AID540308, Type: screening] | melanocortin receptor 4 [Homo sapiens] [gi:119508433] |  View X | Row No. | 41 | | Structure |
| | Substance | | | SID | 47193677 | | CID | 7991 | | Outcome | Inactive | | BioAssay | Luminescence-based cell-based primary high throughput screening assay to identify biased ligands of the melanocortin 4 receptor (MC4R): agonists of MC4R | | AID | 540308 | | BioAssay type | screening | | Target | melanocortin receptor 4 [Homo sapiens] [gi:119508433] | | PubMed | | | Data Table |  |
|
| 42 | [SID47193677] | Inactive | | | Luminescence-based cell-based primary high throughput screening assay to identify biased ligands of the melanocortin 4 receptor (MC4R): agonists of MC4R [AID540308, Type: screening] | melanocortin receptor 4 [Homo sapiens] [gi:119508433] |  View X | Row No. | 42 | | Structure |
| | Substance | | | SID | 47193677 | | CID | 7991 | | Outcome | Inactive | | BioAssay | Luminescence-based cell-based primary high throughput screening assay to identify biased ligands of the melanocortin 4 receptor (MC4R): agonists of MC4R | | AID | 540308 | | BioAssay type | screening | | Target | melanocortin receptor 4 [Homo sapiens] [gi:119508433] | | PubMed | | | Data Table |  |
|
| 43 | [SID47193677] | Inactive | | | TRFRET-based cell-based primary high throughput screening assay to identify biased ligands of the melanocortin 4 receptor (MC4R): antagonists of MC4R [AID540295, Type: screening] | melanocortin receptor 4 [Homo sapiens] [gi:119508433] |  View X | Row No. | 43 | | Structure |
| | Substance | | | SID | 47193677 | | CID | 7991 | | Outcome | Inactive | | BioAssay | TRFRET-based cell-based primary high throughput screening assay to identify biased ligands of the melanocortin 4 receptor (MC4R): antagonists of MC4R | | AID | 540295 | | BioAssay type | screening | | Target | melanocortin receptor 4 [Homo sapiens] [gi:119508433] | | PubMed | | | Data Table |  |
|
| 44 | [SID47193677] | Inactive | | | TRFRET-based cell-based primary high throughput screening assay to identify biased ligands of the melanocortin 4 receptor (MC4R): antagonists of MC4R [AID540295, Type: screening] | melanocortin receptor 4 [Homo sapiens] [gi:119508433] |  View X | Row No. | 44 | | Structure |
| | Substance | | | SID | 47193677 | | CID | 7991 | | Outcome | Inactive | | BioAssay | TRFRET-based cell-based primary high throughput screening assay to identify biased ligands of the melanocortin 4 receptor (MC4R): antagonists of MC4R | | AID | 540295 | | BioAssay type | screening | | Target | melanocortin receptor 4 [Homo sapiens] [gi:119508433] | | PubMed | | | Data Table |  |
|
| 45 | [SID47193677] | Inactive | | | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of myeloid cell leukemia sequence 1 (MCL1) interactions with BIM-BH3 peptide. [AID2057, Type: screening] | Myeloid cell leukemia sequence 1 (BCL2-related) [Homo sapiens] [gi:78070770] |  View X | Row No. | 45 | | Structure |
| | Substance | | | SID | 47193677 | | CID | 7991 | | Outcome | Inactive | | BioAssay | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of myeloid cell leukemia sequence 1 (MCL1) interactions with BIM-BH3 peptide. | | AID | 2057 | | BioAssay type | screening | | Target | Myeloid cell leukemia sequence 1 (BCL2-related) [Homo sapiens] [gi:78070770] | | PubMed | | | Data Table |  |
|
| 46 | [SID47193677] | Inactive | | | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of myeloid cell leukemia sequence 1 (MCL1) interactions with BIM-BH3 peptide. [AID2057, Type: screening] | Myeloid cell leukemia sequence 1 (BCL2-related) [Homo sapiens] [gi:78070770] |  View X | Row No. | 46 | | Structure |
| | Substance | | | SID | 47193677 | | CID | 7991 | | Outcome | Inactive | | BioAssay | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of myeloid cell leukemia sequence 1 (MCL1) interactions with BIM-BH3 peptide. | | AID | 2057 | | BioAssay type | screening | | Target | Myeloid cell leukemia sequence 1 (BCL2-related) [Homo sapiens] [gi:78070770] | | PubMed | | | Data Table |  |
|
| 47 | [SID47193677] | Inactive | | | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of myeloid cell leukemia sequence 1 (MCL1) interactions with BIM-BH3 peptide. [AID2057, Type: screening] | Myeloid cell leukemia sequence 1 (BCL2-related) [Homo sapiens] [gi:78070770] |  View X | Row No. | 47 | | Structure |
| | Substance | | | SID | 47193677 | | CID | 7991 | | Outcome | Inactive | | BioAssay | Fluorescence polarization-based primary biochemical high throughput screening assay to identify inhibitors of myeloid cell leukemia sequence 1 (MCL1) interactions with BIM-BH3 peptide. | | AID | 2057 | | BioAssay type | screening | | Target | Myeloid cell leukemia sequence 1 (BCL2-related) [Homo sapiens] [gi:78070770] | | PubMed | | | Data Table |  |
|
| 48 | [SID47193677] | Inactive | | | uHTS for identification of Inhibitors of Mdm2/MdmX interaction in luminescent format. [AID485346, Type: screening] | protein Mdm4 isoform 1 [Homo sapiens] [gi:88702791] |  View X | Row No. | 48 | | Structure |
| | Substance | | | SID | 47193677 | | CID | 7991 | | Outcome | Inactive | | BioAssay | uHTS for identification of Inhibitors of Mdm2/MdmX interaction in luminescent format. | | AID | 485346 | | BioAssay type | screening | | Target | protein Mdm4 isoform 1 [Homo sapiens] [gi:88702791] | | PubMed | | | Data Table |  |
|
| 49 | [SID47193677] | Inactive | | | uHTS for identification of Inhibitors of Mdm2/MdmX interaction in luminescent format. [AID485346, Type: screening] | protein Mdm4 isoform 1 [Homo sapiens] [gi:88702791] |  View X | Row No. | 49 | | Structure |
| | Substance | | | SID | 47193677 | | CID | 7991 | | Outcome | Inactive | | BioAssay | uHTS for identification of Inhibitors of Mdm2/MdmX interaction in luminescent format. | | AID | 485346 | | BioAssay type | screening | | Target | protein Mdm4 isoform 1 [Homo sapiens] [gi:88702791] | | PubMed | | | Data Table |  |
|
| 50 | [SID47193677] | Inactive | | | Multiplex HTS Assay for Inhibitors of MEK Kinase PB1 Domains, specifically MEK5 MEK Kinase3 Wildtype [AID1529, Type: screening] | mitogen-activated protein kinase kinase kinase 3 isoform 1 [Homo sapiens] [gi:42794767] |  View X | Row No. | 50 | | Structure |
| | Substance | | | SID | 47193677 | | CID | 7991 | | Outcome | Inactive | | BioAssay | Multiplex HTS Assay for Inhibitors of MEK Kinase PB1 Domains, specifically MEK5 MEK Kinase3 Wildtype | | AID | 1529 | | BioAssay type | screening | | Target | mitogen-activated protein kinase kinase kinase 3 isoform 1 [Homo sapiens] [gi:42794767] | | PubMed | | | Data Table |  |
|